FOR PREVIEW ONLY (Print)

Shreya Kanodia, PhD

Assistant Professor, Biomedical Sciences

Associate Director for Administration, Cancer Institute

Send an Email

Research Office:

Phone:

310-423-6493

Shreya Kanodia, PhD

Assistant Professor, Biomedical Sciences

Associate Director for Administration, Cancer Institute

The research of Shreya Kanodia, PhD, focuses on pathogenesis, early detection and immunotherapy of mesothelioma.

  • American Association of Cancer Research, 2013
  • National Council of University Research Administrators, 2013
  • Association of American Cancer Institutes/Cancer Center Administrators Forum, 2010
  • NIH Travel Award-International Papillomavirus Society, 2009-10
  • University of Southern California Norris Cancer Center Distinguished Merit Award, 2008-09
  • NIH Travel Award-International Papillomavirus Society, 2006-07
  • Vivian L. Smith Outstanding Young Immunologist Award, 2004-05
  • American Legion Auxilary Fellowship, 2003-05
  • Sowell-Huggins/Sylvan Rodriguez Fellowship, 2003-04
  • MD Anderson Cancer Center Trainee Excellence Award, 2002-03
  • American Society of Hematology Travel Award, 2002-03
  • Women's Travel Scholarship Award, 2001-02

Show moreShow less

Click here for a list of peer-reviewed publications.

  • Carbone M, Baris YI, Bertino P, Brass B, Comertpay S, Dogan AU, Gaudino G, Jube S, Kanodia S, Partridge CR, et al. Erionite exposure in North Dakota and Turkish villages with mesothelioma. Proc Natl Acad Sci U S A. 2011;108(33):13618-13623.
  • Rivera Z, Ferrone S, Wang X, Jube S, Yang H, Pass HI, Kanodia S, Gaudino G, Carbone M. CSPG4 as a target of antibody-based immunotherapy for malignant mesothelioma. Clin Cancer Res. 2012;18(19):5352-5363.
  • Napolitano A, Pellegrini L, Dey A, Larson D, Tanji M, Flores EG, Kendrick B, Lapid D, Powers A, Kanodia S, Pastorino S, Pass HI, Dixit V, Yang H, Carbone M. Minimal asbestos exposure in germline BAP1 heterozygous mice is associated with deregulated inflammatory response and increased risk of mesothelioma. Oncogene. 2016 Apr 14;35(15):1996-2002.
  • Yang H, Pellegrini L, Napolitano A, Giorgi C, Jube S, Preti A, Jennings CJ, De Marchis F, Flores EG, Larson D, Pagano I, Tanji M, Powers A, Kanodia S, Gaudino G, Pastorino S, Pass HI, Pinton P, Bianchi ME, Carbone M. Aspirin delays mesothelioma growth by inhibiting HMGB1-mediated tumor progression. Cell Death Dis. 2015 Jun 11;6:e1786.
  • Nasu M, Emi M, Pastorino S, Tanji M, Powers A, Luk H, Baumann F, Zhang YA, Gazdar A, Kanodia S, Tiirikainen M, Flores E, Gaudino G, Becich MJ, Pass HI, Yang H, Carbone M. High Incidence of Somatic BAP1 alterations in sporadic malignant mesothelioma. J Thorac Oncol. 2015 Apr;10(4):565-76.

Show moreShow less

Many of the physicians who have medical staff privileges to practice medicine at Cedars-Sinai Medical Center are independent physicians, and not employees or agents of the hospital. These independent physicians bill separately for their services. You should contact your physician to determine their status and billing practices.

Send Email to Shreya Kanodia, PhD